Patients' voices heard: new survey aims to reveal true burden of rheumatic diseases
NCT ID NCT06461000
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is an online survey for 1,000 adults diagnosed with a rheumatic or musculoskeletal disease living in a EULAR country. Participants will answer periodic questionnaires about their healthcare, social life, and work. The goal is to gather real-world data to help researchers and doctors better understand the disease burden and improve patient care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this survey could provide a clearer picture of the real-world burden of rheumatic diseases, helping improve care and support for patients.
- What could go wrong
- This is an observational survey, not a treatment trial. It will not test any new drug or therapy, and results depend on honest, complete responses from participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Jun 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
\- adults with at least 1 RMD
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18-year-old at time of baseline survey * Living in a EULAR country at time of baseline survey * Diagnosed with at least one RMD * Valid personal e-mail address * Being able to use an internet website Exclusion Criteria: * none
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Musculoskeletal diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
EULAR
RECRUITINGKilchberg, Canton of Zurich, 8802, Switzerland
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI predict your lifespan from a short video?
- Lipedema and muscle loss: is there a hidden link?
- Video physiotherapy: a greener, cheaper way to treat pain?
- Ultrasound may reveal hidden bone damage in blood cancers
- Could a gut microbiome transplant ease axial spondyloarthritis?
- A robotic back brace could save Caregivers' spines